Literature DB >> 23118348

Predictors of outcome in 176 South African patients with peripartum cardiomyopathy.

Lori A Blauwet1, Elena Libhaber, Olaf Forster, Kemi Tibazarwa, Alex Mebazaa, Denise Hilfiker-Kleiner, Karen Sliwa.   

Abstract

OBJECTIVE: Identify novel prognostic factors for patients with peripartum cardiomyopathy (PPCM). DESIGN AND
SETTING: Prospective cohort study conducted in a single tertiary care centre in South Africa. PATIENTS: 176 African women with newly diagnosed PPCM were studied.
INTERVENTIONS: Clinical assessment, echocardiography and laboratory results were obtained at baseline and at 6 months. MAIN OUTCOME MEASURES: Poor outcome was defined as the combined end point of death, left ventricular (LV) ejection fraction (LVEF) < 35%, or remaining in New York Heart Association (NYHA) functional class III/IV at 6 months. Complete LV recovery was defined as LVEF ≥55% at 6 months.
RESULTS: Forty-five (26%) patients had a poor outcome. Multiple logistic regression analysis revealed that, after adjustment for age, NYHA functional class, LVEF and systolic blood pressure, increased left ventricular end systolic dimension (LVESD), lower body mass index (BMI) and lower total cholesterol at baseline were independent predictors of poor outcome (adjusted OR 1.09, 95% CI 1.04 to 1.15, p=0.001; OR 0.89, 95% CI 0.83 to 0.96, p=0.004, and OR 0.50, 95% CI 0.34 to 0.73, p=0.0004, respectively). Thirty (21%) of the 141 surviving patients with echocardiographic follow-up recovered LV function at 6 months. Multiple logistic regression analysis revealed that, after adjustment for NYHA functional class, LVEF and left ventricular end diastolic dimension, older age and smaller LVESD at baseline were predictors of LV recovery (OR 1.08, 95% CI 1.01 to 1.17, p=0.02 and OR 0.92, 95% CI 0.86 to 0.98, p=0.007, respectively).
CONCLUSIONS: This study suggests that increased LVESD, lower BMI and lower serum cholesterol at baseline may be independent predictors of poor outcome in patients with PPCM, while older age and smaller LVESD at baseline appear to be independently associated with a higher chance of LV recovery.

Entities:  

Mesh:

Year:  2012        PMID: 23118348     DOI: 10.1136/heartjnl-2012-302760

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  27 in total

Review 1.  Pathophysiology and epidemiology of peripartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karen Sliwa
Journal:  Nat Rev Cardiol       Date:  2014-04-01       Impact factor: 32.419

2.  Importance of Early Diagnosis in Peripartum Cardiomyopathy.

Authors:  Jennifer Lewey; Lisa D Levine; Michal A Elovitz; Olga C Irizarry; Zoltan Arany
Journal:  Hypertension       Date:  2019-11-11       Impact factor: 10.190

Review 3.  Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.

Authors:  Michael M Givertz; Douglas L Mann
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 4.  Exploring unknowns in cardiology.

Authors:  Ottavio Alfieri; Bongani M Mayosi; Seung-Jung Park; Nizal Sarrafzadegan; Renu Virmani
Journal:  Nat Rev Cardiol       Date:  2014-09-23       Impact factor: 32.419

5.  Peripartum cardiomyopathy: An analysis of clinical profiles and outcomes from a tertiary care centre in southern India.

Authors:  Aditya John Binu; Sudha Jasmine Rajan; Swati Rathore; Manisha Beck; Annie Regi; Viji Samuel Thomson; Sowmya Sathyendra
Journal:  Obstet Med       Date:  2019-06-17

Review 6.  The Wearable Cardioverter/Defibrillator - Toy Or Tool?

Authors:  David Duncker; Christian Veltmann
Journal:  J Atr Fibrillation       Date:  2016-04-30

Review 7.  Peripartum Cardiomyopathy and Preeclampsia: Overlapping Diseases of Pregnancy.

Authors:  Pavan Parikh; Lori Blauwet
Journal:  Curr Hypertens Rep       Date:  2018-07-03       Impact factor: 5.369

Review 8.  Molecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis.

Authors:  Natalie A Bello; Zoltan Arany
Journal:  Trends Cardiovasc Med       Date:  2015-01-15       Impact factor: 6.677

9.  In-hospital management and outcomes in patients with peripartum cardiomyopathy: a descriptive study using a national inpatient database in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2017-02-23       Impact factor: 2.037

Review 10.  Bromocriptine for the Treatment of Peripartum Cardiomyopathy.

Authors:  Tobias Koenig; Johann Bauersachs; Denise Hilfiker-Kleiner
Journal:  Card Fail Rev       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.